Update on managing neuropathic pain

International Journal of Pharmaceutical Compounding

Volumn 13, Issue 3, 2009, Pages 182-190

  McNulty, Jack P ^a,b,c   Muller, George ^d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Tammany Parish Schools   (United States)

^c Palliative Care Institute of Southeast Louisiana   (United States)

^d St Albans VA Community Living Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; BUTYLCRESOL; CLONIDINE; EMOLLIENT AGENT; ENDORPHIN; FENTANYL; FLAVORING AGENT; GABAPENTIN; GLYCEROL; HYDROCODONE; HYDROMORPHONE; KAPPA OPIATE RECEPTOR; KETAMINE; KETOPROFEN; LEVORPHANOL; LIDOCAINE; LORAZEPAM; METHADONE; MIDAZOLAM; MORPHINE; MORPHINE SULFATE; MU OPIATE RECEPTOR; OXYCODONE; PALMITIC ACID ISOPROPYL ESTER; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; POLOXAMER; POLYSORBATE 80; SACCHARIN SODIUM; STEVIA EXTRACT; UNCLASSIFIED DRUG;

ANALGESIA; ARTICLE; BEDTIME DOSAGE; CHRONIC PAIN; DECUBITUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG LABELING; DRUG PACKAGING; DRUG STABILITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GEL; HUMAN; LOW BACK PAIN; NEUROPATHIC PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE; QUALITY OF LIFE; SPINAL CORD; SYRUP;

EID: 70350129953     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brookoff D. Chronic pain: 1. A new disease? Hosp Pract (Minneap) 2000; 35(7): 45-52, 59.
2. Brookoff D. Chronic pain: 2. The case for opioids. Hosp Pract (Minneap) 2000; 35(9): 69-72, 75-76, 81-94.
3. Fine P. Ketamine: From anesthesia to palliative care. AAHPM Bull 2003; 3(3): 1, 6.
4. Annetta MG, Iemma D, Garisto C et al. Ketamine: New indications for an old drug. Curr Drug Targets 2005; 6(7): 789-794.
5. Carr DB, Goudas LC, Denman WT et al. Safety and efficacy of intranasal ketamine in a mixed population with chronic pain. Pain 2004; 110(3): 762-764.
6. Kronenberg RH. Ketamine as an analgesic: Parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother 2002; 16(3): 27-35.
7. Pöyhiä R, Vainio A. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin J Pain 2006; 22(1): 32-36.
8. Rowbotham MC, Twilling L, Davies PS et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348(13): 1223-1232.
9. Fischberg D, Morrison RS. Update in hospice and palliative care 2003. J Palliat Med 2004; 7(4): 574-578.
10. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med 2003; 348(13): 1279-1281.
11. Wheeler WL, Dickerson ED. Clinical applications of methadone. Am J Hosp Palliat Care 2000; 17(3): 196-203.
12. Bruera E, Sweeney C. Methadone use in cancer patients with pain: A review. J Palliat Med 2002; 5(1): 127-138.
13. Baumrucker SJ. Politics, cancer pain, and methadone. Am J Hosp Palliat Care 2000; 17(3): 153-154.